Cargando…
Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?
The aim of treatment for idiopathic central precocious puberty (ICPP) is to increase final adult stature, for which gonadotropin-releasing hormone agonist (GnRHa) is the gold standard. Early puberty is frequently similar to ICPP, with pubertal onset only slightly advanced. Short stature may result f...
Autores principales: | Song, Wei, Zhao, Fei, Liang, Shuang, Li, Guimei, Xue, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332953/ https://www.ncbi.nlm.nih.gov/pubmed/30693027 http://dx.doi.org/10.1155/2018/1708650 |
Ejemplares similares
-
GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls
por: Ying, Yanqin, et al.
Publicado: (2017) -
Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
por: Nam, Hyo-Kyoung, et al.
Publicado: (2017) -
Leptin and adiponectin levels in girls with central precocious puberty before and during GnRH agonist treatment
por: Yoo, Jae Won, et al.
Publicado: (2016) -
Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013) -
Challenges in monitoring GnRH analog treatment in central precocious puberty
por: Latronico, Ana Claudia
Publicado: (2020)